Table of Content

Introduction
Executive Summary
T-cell Surface Glycoprotein CD4: Overview
• SYK Receptor - Overview
• Structure and Signaling of the SYK Receptor
• Regulation of Synthesis and Release of SYK
• SYK Metabolism
• SYK Receptor Antagonists
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
T-cell Surface Glycoprotein CD4
In-depth Commercial Assessment
• T-cell Surface Glycoprotein CD4 companies’ collaborations, Licensing, Acquisition -Deal Value Trends
T-cell Surface Glycoprotein CD4 Collaboration Deals
• Company-Company Collaborations (Licensing / Partnering) Analysis
• Company-University Collaborations (Licensing / Partnering) Analysis
Early Stage Products (Phase I)
• Comparative Analysis
SAR 441236: Sanofi
• Product Description
• Research and Development
• Product Development Activities
Pre-clinical and Discovery Stage Products
• Comparative Analysis
Ibalizumab: TaiMed Biologics
• Product Description
• Research and Development
• Product Development Activities
Inactive Products
Comparative Analysis
• T-cell Surface Glycoprotein CD4 Key Companies
• T-cell Surface Glycoprotein CD4 Key Products
• T-cell Surface Glycoprotein CD4- Unmet Needs
T-cell Surface Glycoprotein CD4- Market Drivers and Barriers
• T-cell Surface Glycoprotein CD4- Future Perspectives and Conclusion
• T-cell Surface Glycoprotein CD4 Analyst Views
• T-cell Surface Glycoprotein CD4 Key Companies
Appendix



List of Figures


Figure 1 Total Products for T-cell Surface Glycoprotein CD4
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products

 

List of Tables


Table 1 Total Products for T-cell Surface Glycoprotein CD4
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products